GeoVax Labs (GOVX) Assets (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Assets of $4.6 million for Q2 2026, down 13.23% year-over-year from $5.4 million in Q2 2025, and down 26.79% quarter-over-quarter from $6.3 million in Q4 2025.
GeoVax Labs (GOVX) Assets (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Assets for 17 consecutive years, with $4.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets fell 13.23% year-over-year to $4.6 million; the TTM figure through Jun 2026 stood at $4.6 million (down 13.23% YoY), while the FY2025 annual figure was $6.3 million, down 22.24% from the prior year.
- Assets fell to $4.6 million in Q2 2026 per GOVX's latest filing, from $6.3 million in the prior quarter.
- Across five years, Assets topped out at $38.6 million in Q3 2022 and bottomed at $3.4 million in Q1 2024.
- Historically, Assets has averaged $15.0 million across 5 years, with a median of $10.8 million in 2025.
- Annual changes were most pronounced in 2024 — Assets plunged 87.75% — and 2025, when it jumped 222.6%.
- GeoVax Labs' Assets stood at $31.3 million in 2022, then slumped by 70.39% to $9.3 million in 2023, then dropped by 12.14% to $8.2 million in 2024, then fell by 22.24% to $6.3 million in 2025, then slipped by 26.79% to $4.6 million in 2026.
- Business Quant data shows GOVX's Assets at $4.6 million in Q2 2026, $6.3 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | GeoVax Labs | 2.89 Mn | -252,732.97 | - | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 10.83 Mn |
| Dec 31, 2024 | 8.16 Mn |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 9.28 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | 21.25 Mn |
| Mar 31, 2023 | 27.40 Mn |
| Dec 31, 2022 | 31.35 Mn |
| Sep 30, 2022 | 38.57 Mn |
| Jun 30, 2022 | 33.24 Mn |
| Mar 31, 2022 | 16.85 Mn |
| Dec 31, 2021 | 11.80 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 19.82 Mn |